Influenza Vaccines: Global Markets
Report Scope:
The report explains critical trends in the influenza vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.
This report study includes only human vaccines; animal vaccines have not been considered in this report.
This study looks at most of the systems affected by factors such as considerable research and development spending and increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.
Company merger acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type considering new technologies, growing competition and changing customer needs.
The market has also been analyzed based on the type of influenza vaccines. Categories considered in this report include inactivated vaccines and live-attenuated vaccines.
This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories and various hospital settings, as well as pharmaceutical, diagnostic and biotechnology companies and physicians, will find this study to be of interest.
The report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.
Report Includes:
The report explains critical trends in the influenza vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to stakeholders and potential entrants.
This report study includes only human vaccines; animal vaccines have not been considered in this report.
This study looks at most of the systems affected by factors such as considerable research and development spending and increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.
Company merger acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type considering new technologies, growing competition and changing customer needs.
The market has also been analyzed based on the type of influenza vaccines. Categories considered in this report include inactivated vaccines and live-attenuated vaccines.
This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories and various hospital settings, as well as pharmaceutical, diagnostic and biotechnology companies and physicians, will find this study to be of interest.
The report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.
Report Includes:
- 20 data tables and 29 additional tables
- An updated overview of the global market for influenza vaccines within the biopharmaceutical industry
- Analyses of the global market trends, with historic revenue (sales) data for 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the market size for influenza vaccines, and corresponding market share analysis by type, technology, age, and region
- Information on baloxavir marboxil (Xofluza) vaccine, along with types of influenza virus strains used for vaccine preparation like influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain
- Country specific data and market value analysis for the U.S., Canada, Germany, U.K., France, Italy, Spain, Australia, Japan, China and India
- Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2026)
- Discussion of technology advancements in influenza vaccines development, product innovations, government regulations, clinical trials, and other key market strategies
- Coverage of key merger acquisition strategies and collaboration agreements in the marketplace
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
CHAPTER 1 INTRODUCTION
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Definitions
Immune System and Vaccines
How Vaccines Work?
Influenza Vaccines - Overview
The Pathogen
Signs and Symptoms
Epidemiology
Diagnosis
Prevention
Type of Influenza Vaccines
Annual Selection of Viruses
Production
Inactivated Influenza Vaccines (IIVs)
Live-attenuated Influenza Vaccines (LAIVs)
Regulatory Aspects
CHAPTER 4 IMPACT OF COVID-19
Overview
Impact of Covid-19 on the 2021-2022 Flu Season
Low Levels of Flu May Lead to Contentment About Getting the Vaccine
Positive Impact of Covid-19 on Flu Vaccination Rates
Influenza Vaccination Increased During the Covid-19 Pandemic
CHAPTER 5 INFLUENZA VACCINES MARKET DYNAMICS
Market Drivers
Increase in Government Support and Surveillance Regarding Vaccination Against Influenza at the National and Global Levels
Growing Awareness of Immunization Across the Globe
The Rise in Investment by Top Market Players Across the Globe and Growth in Government Funding Has Facilitated the Launch of Therapeutically Effective Vaccines
Market Restraints
Stringent Regulatory Requirements Along with Prolonged Duration of Clinical Trials
Limited Adoption of Influenza Vaccines in Low- and Middle-Income Countries (LMICs)
Market Opportunities
Demand for Universal Flu Vaccines Fuels the Need to Develop Innovative Approaches for Vaccine Development
Competitive Landscape
Company Share Analysis
CHAPTER 6 MARKET BREAKDOWN BY TYPE
Global Influenza Vaccines Market, by Type
Inactivated Vaccines
Market Size and Forecast
Live-attenuated Vaccines
Market Size and Forecast
CHAPTER 7 MARKET BREAKDOWN BY TECHNOLOGY
Global Influenza Vaccines Market, by Technology
Egg-based
Market Size and Forecast
Cell-based Vaccine
Market Size and Forecast
CHAPTER 8 MARKET BREAKDOWN BY AGE
Global Influenza Vaccines Market, by Age
Pediatric
Market Size and Forecast
Adults
Among Adults, Who Should Not Get the Flu Vaccine?
Market Size and Forecast
CHAPTER 9 MARKET BREAKDOWN BY REGION
Global Influenza Vaccines Market, by Region
North America
U.S.
Canada
Europe
National Recommendations Across Europe
Achieved Coverage
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
CHAPTER 10 COMPANY PROFILES
ABBOTT LABORATORIES
ASTRAZENECA PLC
BIODIEM LTD.
BHARAT BIOTECH INTERNATIONAL LTD.
CSL LTD.
EMERGENT BIOSOLUTIONS INC.
GLAXOSMITHKLINE PLC
GC BIOPHARMA (GREEN CROSS CORP.)
NOVAVAX INC.
SANOFI
SINOVAC BIOTECH LTD.
CHAPTER 11 APPENDIX: LIST OF ABBREVIATIONS
Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Definitions
Immune System and Vaccines
How Vaccines Work?
Influenza Vaccines - Overview
The Pathogen
Signs and Symptoms
Epidemiology
Diagnosis
Prevention
Type of Influenza Vaccines
Annual Selection of Viruses
Production
Inactivated Influenza Vaccines (IIVs)
Live-attenuated Influenza Vaccines (LAIVs)
Regulatory Aspects
CHAPTER 4 IMPACT OF COVID-19
Overview
Impact of Covid-19 on the 2021-2022 Flu Season
Low Levels of Flu May Lead to Contentment About Getting the Vaccine
Positive Impact of Covid-19 on Flu Vaccination Rates
Influenza Vaccination Increased During the Covid-19 Pandemic
CHAPTER 5 INFLUENZA VACCINES MARKET DYNAMICS
Market Drivers
Increase in Government Support and Surveillance Regarding Vaccination Against Influenza at the National and Global Levels
Growing Awareness of Immunization Across the Globe
The Rise in Investment by Top Market Players Across the Globe and Growth in Government Funding Has Facilitated the Launch of Therapeutically Effective Vaccines
Market Restraints
Stringent Regulatory Requirements Along with Prolonged Duration of Clinical Trials
Limited Adoption of Influenza Vaccines in Low- and Middle-Income Countries (LMICs)
Market Opportunities
Demand for Universal Flu Vaccines Fuels the Need to Develop Innovative Approaches for Vaccine Development
Competitive Landscape
Company Share Analysis
CHAPTER 6 MARKET BREAKDOWN BY TYPE
Global Influenza Vaccines Market, by Type
Inactivated Vaccines
Market Size and Forecast
Live-attenuated Vaccines
Market Size and Forecast
CHAPTER 7 MARKET BREAKDOWN BY TECHNOLOGY
Global Influenza Vaccines Market, by Technology
Egg-based
Market Size and Forecast
Cell-based Vaccine
Market Size and Forecast
CHAPTER 8 MARKET BREAKDOWN BY AGE
Global Influenza Vaccines Market, by Age
Pediatric
Market Size and Forecast
Adults
Among Adults, Who Should Not Get the Flu Vaccine?
Market Size and Forecast
CHAPTER 9 MARKET BREAKDOWN BY REGION
Global Influenza Vaccines Market, by Region
North America
U.S.
Canada
Europe
National Recommendations Across Europe
Achieved Coverage
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
Australia
India
Rest of Asia-Pacific
Rest of the World
Market Size and Forecast
CHAPTER 10 COMPANY PROFILES
ABBOTT LABORATORIES
ASTRAZENECA PLC
BIODIEM LTD.
BHARAT BIOTECH INTERNATIONAL LTD.
CSL LTD.
EMERGENT BIOSOLUTIONS INC.
GLAXOSMITHKLINE PLC
GC BIOPHARMA (GREEN CROSS CORP.)
NOVAVAX INC.
SANOFI
SINOVAC BIOTECH LTD.
CHAPTER 11 APPENDIX: LIST OF ABBREVIATIONS
LIST OF TABLES
Summary Table: Global Influenza Vaccines Market, by Type, Through 2026
Table 1: Seasonal Influenza Vaccines
Table 2: U.S. Influenza Vaccines for the 2021–2022 Influenza Season
Table 3: Global Influenza Vaccines Market, by Type, Through 2026
Table 4: Global Inactivated Influenza Vaccines Market, by Region, Through 2026
Table 5: Global Live-attenuated Influenza Vaccines Market, by Region, Through 2026
Table 6: Global Influenza Vaccines Market, by Technology, Through 2026
Table 7: Egg-based Influenza Vaccine Products for 2021–2022 Influenza Season
Table 8: Global Egg-based Influenza Vaccines Market, by Region, Through 2026
Table 9: Global Cell-based Influenza Vaccines Market, by Region, Through 2026
Table 10: Global Influenza Vaccines Market, by Age, Through 2026
Table 11: Influenza Vaccines by Age
Table 12: Influenza Vaccine Price List, 2020
Table 13: Global Market for Pediatrics in Influenza Vaccines, by Region, Through 2026
Table 14: Global Market for Adults in Influenza Vaccines, by Region, Through 2026
Table 15: Global Influenza Vaccines Market, by Region, Through 2026
Table 16: North American Influenza Vaccines Market, by Type, Through 2026
Table 17: North American Influenza Vaccines Market, by Country, Through 2026
Table 18: U.S. Cumulative 2021/2022 Season Lot Release Status (Updated 11/3/2021)
Table 19: Overview of Available Seasonal Influenza Vaccines in the E.U./E.E.A.
Table 20: European Influenza Vaccines Market, by Type, Through 2026
Table 21: European Influenza Vaccines Market, by Country, Through 2026
Table 22: Influenza Vaccines Marketed in the U.K. for the 2022–2023 Influenza Season
Table 23: Asia-Pacific Influenza Vaccines Market, by Type, Through 2026
Table 24: Asia-Pacific Influenza Vaccines Market, by Country, Through 2026
Table 25: Rest of the World Influenza Vaccines Market, by Type, Through 2026
Table 26: Abbott Laboratories: Vaccines Offered
Table 27: AstraZeneca: Vaccines Offered
Table 28: AstraZeneca: Recent Developments
Table 29: BioDiem Ltd.: Vaccines Offered
Table 30: BioDiem Ltd.: Recent Developments
Table 31: Bharat Biotech: Vaccines Offered
Table 32: Bharat Biotech: Recent Developments
Table 33: CSL Ltd. (Seqirus): Vaccines Offered
Table 34: CSL Ltd. (Seqirus): Recent Developments
Table 35: Emergent BioSolutions Inc.: Vaccines Offered
Table 36: Emergent BioSolutions Inc.: Recent Developments
Table 37: GlaxoSmithKline plc: Vaccines Offered
Table 38: GlaxoSmithKline plc: Flu Vaccines Sales, 2019–2020
Table 39: GlaxoSmithKline plc: Recent Developments
Table 40: GC Biopharma: Vaccines Offered
Table 41: GC Biopharma: Recent Developments
Table 42: Novavax Inc.: Vaccines Offered
Table 43: Novavax Inc.: Recent Developments
Table 44: Sanofi: Vaccines Offered
Table 45: Sanofi: Recent Developments
Table 46: Sinovac Biotech Ltd.: Vaccines Offered
Table 47: Sinovac Biotech Ltd.: Recent Developments
Table 48: Abbreviations Used in the Vaccine Technologies Market
Summary Table: Global Influenza Vaccines Market, by Type, Through 2026
Table 1: Seasonal Influenza Vaccines
Table 2: U.S. Influenza Vaccines for the 2021–2022 Influenza Season
Table 3: Global Influenza Vaccines Market, by Type, Through 2026
Table 4: Global Inactivated Influenza Vaccines Market, by Region, Through 2026
Table 5: Global Live-attenuated Influenza Vaccines Market, by Region, Through 2026
Table 6: Global Influenza Vaccines Market, by Technology, Through 2026
Table 7: Egg-based Influenza Vaccine Products for 2021–2022 Influenza Season
Table 8: Global Egg-based Influenza Vaccines Market, by Region, Through 2026
Table 9: Global Cell-based Influenza Vaccines Market, by Region, Through 2026
Table 10: Global Influenza Vaccines Market, by Age, Through 2026
Table 11: Influenza Vaccines by Age
Table 12: Influenza Vaccine Price List, 2020
Table 13: Global Market for Pediatrics in Influenza Vaccines, by Region, Through 2026
Table 14: Global Market for Adults in Influenza Vaccines, by Region, Through 2026
Table 15: Global Influenza Vaccines Market, by Region, Through 2026
Table 16: North American Influenza Vaccines Market, by Type, Through 2026
Table 17: North American Influenza Vaccines Market, by Country, Through 2026
Table 18: U.S. Cumulative 2021/2022 Season Lot Release Status (Updated 11/3/2021)
Table 19: Overview of Available Seasonal Influenza Vaccines in the E.U./E.E.A.
Table 20: European Influenza Vaccines Market, by Type, Through 2026
Table 21: European Influenza Vaccines Market, by Country, Through 2026
Table 22: Influenza Vaccines Marketed in the U.K. for the 2022–2023 Influenza Season
Table 23: Asia-Pacific Influenza Vaccines Market, by Type, Through 2026
Table 24: Asia-Pacific Influenza Vaccines Market, by Country, Through 2026
Table 25: Rest of the World Influenza Vaccines Market, by Type, Through 2026
Table 26: Abbott Laboratories: Vaccines Offered
Table 27: AstraZeneca: Vaccines Offered
Table 28: AstraZeneca: Recent Developments
Table 29: BioDiem Ltd.: Vaccines Offered
Table 30: BioDiem Ltd.: Recent Developments
Table 31: Bharat Biotech: Vaccines Offered
Table 32: Bharat Biotech: Recent Developments
Table 33: CSL Ltd. (Seqirus): Vaccines Offered
Table 34: CSL Ltd. (Seqirus): Recent Developments
Table 35: Emergent BioSolutions Inc.: Vaccines Offered
Table 36: Emergent BioSolutions Inc.: Recent Developments
Table 37: GlaxoSmithKline plc: Vaccines Offered
Table 38: GlaxoSmithKline plc: Flu Vaccines Sales, 2019–2020
Table 39: GlaxoSmithKline plc: Recent Developments
Table 40: GC Biopharma: Vaccines Offered
Table 41: GC Biopharma: Recent Developments
Table 42: Novavax Inc.: Vaccines Offered
Table 43: Novavax Inc.: Recent Developments
Table 44: Sanofi: Vaccines Offered
Table 45: Sanofi: Recent Developments
Table 46: Sinovac Biotech Ltd.: Vaccines Offered
Table 47: Sinovac Biotech Ltd.: Recent Developments
Table 48: Abbreviations Used in the Vaccine Technologies Market
LIST OF FIGURES
Summary Figure: Global Influenza Vaccines Market Share, by Type, 2020
Figure 1: Timeline of Influenza Vaccine History
Figure 2: Global Influenza Vaccines Market Share, by Companies, 2020
Figure 3: Global Influenza Vaccines Market Share, by Type, 2020
Figure 4: Global Inactivated Influenza Vaccines Market, 2019–2026
Figure 5: Global Inactivated Influenza Vaccines Market, by Region, 2019–2026
Figure 6: Global Live-attenuated Influenza Vaccines Market, 2019–2026
Figure 7: Global Live-attenuated Influenza Vaccines Market, by Region, 2019–2026
Figure 8: Global Market Share for Influenza Vaccines, by Technology, 2020
Figure 9: Global Egg-based Influenza Vaccines Market, 2019–2026
Figure 10: Global Egg-based Influenza Vaccines Market, by Region, 2019–2026
Figure 11: Evolution of Influenza Vaccine Substrates from Embryonated Eggs to Cells
Figure 12: Global Cell-based Influenza Vaccines Market, 2019–2026
Figure 13: Global Cell-based Influenza Vaccines Market, by Region, 2019–2026
Figure 14: Global Market Share for Influenza Vaccines, by Age, 2020
Figure 15: Global Market for Pediatrics in Influenza Vaccines, 2019–2026
Figure 16: Global Market for Pediatrics in Influenza Vaccines, by Region, 2019–2026
Figure 17: Global Market for Adults in Influenza Vaccines, 2019–2026
Figure 18: Global Market for Adults in Influenza Vaccines, by Region, 2019–2026
Figure 19: Global Influenza Vaccines Market, by Region, 2019–2026
Figure 20: Global Influenza Vaccines Market Share, by Region, 2020
Figure 21: North American Influenza Vaccines Market Share, by Technology, 2020
Figure 22: North American Influenza Vaccines Market Share, by Country, 2020
Figure 23: U.S. Influenza Vaccines Market, 2019–2026
Figure 24: Canadian Seasonal Flu Vaccination Coverage, 2018–2019 to 2020–2021 Flu Seasons
Figure 25: Canadian Influenza Vaccines Market, 2019–2026
Figure 26: European Influenza Vaccines Market Share, by Type, 2020
Figure 27: European Influenza Vaccines Market Share, by Country, 2020
Figure 28: German Influenza Vaccines Market, 2019–2026
Figure 29: French Influenza Vaccines Market, 2019–2026
Figure 30: U.K. Influenza Vaccines Market, 2019–2026
Figure 31: Italian Influenza Vaccines Market, 2019–2026
Figure 32: Spanish Influenza Vaccines Market, 2019–2026
Figure 33: Rest of the European Influenza Vaccines Market, 2019–2026
Figure 34: Asia-Pacific Influenza Vaccines Market Share, by Type, 2020
Figure 35: Asia-Pacific Influenza Vaccines Market Share, by Country, 2020
Figure 36: Chinese Influenza Vaccines Market, 2019–2026
Figure 37: Japanese Influenza Vaccines Market, 2019–2026
Figure 38: Australian Influenza Vaccines Market, 2019–2026
Figure 39: Indian Influenza Vaccines Market, 2019–2026
Figure 40: Rest of Asia-Pacific Influenza Vaccines Market, 2019–2026
Figure 41: Rest of the World Influenza Vaccines Market Share, by Type, 2020
Figure 42: Abbott Laboratories: Net Revenue, 2016–2020
Figure 43: Abbott Laboratories: Revenue Share, by Business Segment, 2020
Figure 44: Abbott Laboratories: Revenue Share, by Country, 2020
Figure 45: AstraZeneca: Net Revenue, 2017–2021
Figure 46: AstraZeneca: Revenue Share, by Business Segment, 2021
Figure 47: AstraZeneca: Revenue Share, by Region, 2021
Figure 48: CSL Ltd. (Seqirus): Net Revenue, 2017–2021
Figure 49: CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
Figure 50: Emergent BioSolutions Inc.: Net Revenue, 2016–2020
Figure 51: GlaxoSmithKline plc: Net Revenue, 2016–2020
Figure 52: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 53: GlaxoSmithKline plc: Revenue Share, by Region, 2020
Figure 54: Novavax Inc.: Net Revenue, 2016–2020
Figure 55: Novavax Inc.: Revenue Share, by Business Segment, 2020
Figure 56: Novavax Inc.: Revenue Share, by Region, 2020
Figure 57: Sanofi: Net Revenue, 2017–2021
Figure 58: Sanofi: Revenue Share, by Business Segment, 2021
Figure 59: Sanofi: Revenue Share, by Region, 2021
Summary Figure: Global Influenza Vaccines Market Share, by Type, 2020
Figure 1: Timeline of Influenza Vaccine History
Figure 2: Global Influenza Vaccines Market Share, by Companies, 2020
Figure 3: Global Influenza Vaccines Market Share, by Type, 2020
Figure 4: Global Inactivated Influenza Vaccines Market, 2019–2026
Figure 5: Global Inactivated Influenza Vaccines Market, by Region, 2019–2026
Figure 6: Global Live-attenuated Influenza Vaccines Market, 2019–2026
Figure 7: Global Live-attenuated Influenza Vaccines Market, by Region, 2019–2026
Figure 8: Global Market Share for Influenza Vaccines, by Technology, 2020
Figure 9: Global Egg-based Influenza Vaccines Market, 2019–2026
Figure 10: Global Egg-based Influenza Vaccines Market, by Region, 2019–2026
Figure 11: Evolution of Influenza Vaccine Substrates from Embryonated Eggs to Cells
Figure 12: Global Cell-based Influenza Vaccines Market, 2019–2026
Figure 13: Global Cell-based Influenza Vaccines Market, by Region, 2019–2026
Figure 14: Global Market Share for Influenza Vaccines, by Age, 2020
Figure 15: Global Market for Pediatrics in Influenza Vaccines, 2019–2026
Figure 16: Global Market for Pediatrics in Influenza Vaccines, by Region, 2019–2026
Figure 17: Global Market for Adults in Influenza Vaccines, 2019–2026
Figure 18: Global Market for Adults in Influenza Vaccines, by Region, 2019–2026
Figure 19: Global Influenza Vaccines Market, by Region, 2019–2026
Figure 20: Global Influenza Vaccines Market Share, by Region, 2020
Figure 21: North American Influenza Vaccines Market Share, by Technology, 2020
Figure 22: North American Influenza Vaccines Market Share, by Country, 2020
Figure 23: U.S. Influenza Vaccines Market, 2019–2026
Figure 24: Canadian Seasonal Flu Vaccination Coverage, 2018–2019 to 2020–2021 Flu Seasons
Figure 25: Canadian Influenza Vaccines Market, 2019–2026
Figure 26: European Influenza Vaccines Market Share, by Type, 2020
Figure 27: European Influenza Vaccines Market Share, by Country, 2020
Figure 28: German Influenza Vaccines Market, 2019–2026
Figure 29: French Influenza Vaccines Market, 2019–2026
Figure 30: U.K. Influenza Vaccines Market, 2019–2026
Figure 31: Italian Influenza Vaccines Market, 2019–2026
Figure 32: Spanish Influenza Vaccines Market, 2019–2026
Figure 33: Rest of the European Influenza Vaccines Market, 2019–2026
Figure 34: Asia-Pacific Influenza Vaccines Market Share, by Type, 2020
Figure 35: Asia-Pacific Influenza Vaccines Market Share, by Country, 2020
Figure 36: Chinese Influenza Vaccines Market, 2019–2026
Figure 37: Japanese Influenza Vaccines Market, 2019–2026
Figure 38: Australian Influenza Vaccines Market, 2019–2026
Figure 39: Indian Influenza Vaccines Market, 2019–2026
Figure 40: Rest of Asia-Pacific Influenza Vaccines Market, 2019–2026
Figure 41: Rest of the World Influenza Vaccines Market Share, by Type, 2020
Figure 42: Abbott Laboratories: Net Revenue, 2016–2020
Figure 43: Abbott Laboratories: Revenue Share, by Business Segment, 2020
Figure 44: Abbott Laboratories: Revenue Share, by Country, 2020
Figure 45: AstraZeneca: Net Revenue, 2017–2021
Figure 46: AstraZeneca: Revenue Share, by Business Segment, 2021
Figure 47: AstraZeneca: Revenue Share, by Region, 2021
Figure 48: CSL Ltd. (Seqirus): Net Revenue, 2017–2021
Figure 49: CSL Ltd. (Seqirus): Revenue Share, by Business Segment, 2021
Figure 50: Emergent BioSolutions Inc.: Net Revenue, 2016–2020
Figure 51: GlaxoSmithKline plc: Net Revenue, 2016–2020
Figure 52: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2020
Figure 53: GlaxoSmithKline plc: Revenue Share, by Region, 2020
Figure 54: Novavax Inc.: Net Revenue, 2016–2020
Figure 55: Novavax Inc.: Revenue Share, by Business Segment, 2020
Figure 56: Novavax Inc.: Revenue Share, by Region, 2020
Figure 57: Sanofi: Net Revenue, 2017–2021
Figure 58: Sanofi: Revenue Share, by Business Segment, 2021
Figure 59: Sanofi: Revenue Share, by Region, 2021
